INDRAPRASTHA MEDICAL CORP.LTD.

Indraprastha Medical Corporation Ltd has released its Annual Report for the financial year ended March 31, 2026, along with the Notice of the 38th Annual General Meeting (AGM) scheduled for September 24, 2026. The report also includes the Business Responsibility and Sustainability Report for FY 2025-26. Key highlights from the report indicate a market capitalization of ₹3413.44 crore as of March 31, 2026, and a declared dividend of ₹4 per share. The company emphasizes its commitment to transforming healthcare through clinical excellence, scientific discovery, and digital innovation, focusing on anticipating health risks and personalized care. The report details advancements in AI-led capabilities, including a Clinical Intelligence Engine and an intelligent healthcare ecosystem, alongside the expansion of robotic surgery networks to 42 systems, facilitating over 7,000 robotic-assisted surgeries in FY 2025-26.

Indraprastha Medical Corporation Ltd has filed its Annual Report for the financial year ended March 31, 2026, along with the notice for its 38th Annual General Meeting (AGM) scheduled for September 24, 2026. The report includes the Business Responsibility and Sustainability Report. Key financial highlights mentioned are a market capitalization of ₹3413.44 crore as of March 31, 2026, and a declared dividend of ₹4 per share. The AGM will be conducted via Video Conference and Other Audio Visual Means. The company emphasizes a strategic focus on integrating clinical excellence with digital innovation, AI-led capabilities, and preventive healthcare programs like Apollo ProHealth to address the rising incidence of non-communicable diseases.

Indraprastha Medical Corporation Ltd has announced that its 38th Annual General Meeting (AGM) will be held on Thursday, September 24, 2026, via Video Conferencing and Other Audio-Visual Means. The cut-off date for determining eligible members to vote or attend the AGM has been set as Friday, September 18, 2026. Additionally, the record date for the declaration of a dividend for the financial year 2025-26 is also Friday, September 18, 2026. The proposed dividend is ₹4.00 per share (40% on face value of ₹10), which will be paid within 30 days of declaration if approved by the members at the AGM. Payment will be made to beneficial owners in dematerialized form and members holding shares in physical form.

Indraprastha Medical Corporation Ltd announced that its Board of Directors, in a meeting held on August 6, 2026, approved convening the 38th Annual General Meeting (AGM) on September 24, 2026, through video conferencing. The board also considered and approved the un-audited financial results for the quarter ended June 30, 2026, along with the Limited Review Report. A record date of September 18, 2026, was fixed for determining dividend entitlement for FY2025-26 and for the AGM. Additionally, M/s Devarajan Swaminathan and Co. were re-appointed as Cost Auditors for FY2026-27.

Indraprastha Medical Corporation Ltd announced its un-audited financial results for the quarter ended June 30, 2026. The Board of Directors also approved convening the 38th Annual General Meeting on September 24, 2026, and fixed September 18, 2026, as the record date for dividend and AGM purposes. The company re-appointed M/s Devarajan Swaminathan and Co. as Cost Auditors for FY 2026-27. The financial results will be published in newspapers and posted on the company website.

Indraprastha Medical Corporation Ltd announced that its Board of Directors, in a meeting held on August 6, 2026, approved the fixation of the record date as September 18, 2026, for determining shareholders eligible for dividend payment for the financial year 2025-26. The board also approved the unaudited financial results for the quarter ended June 30, 2026, and convened the 38th Annual General Meeting for September 24, 2026. Additionally, the company re-appointed M/s Devarajan Swaminathan and Co. as Cost Auditors for FY 2026-27.

Indraprastha Medical Corporation Ltd has announced that its Board of Directors will convene on August 6, 2026. The primary agenda item for this meeting is to consider and approve the unaudited financial results for the first quarter ended June 30, 2026. This notification is in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Indraprastha Medical Corporation Ltd has announced the closure of its trading window for all designated persons, including promoters, directors, KMPs, and employees, from July 1, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and will remain in effect until 48 hours after the declaration of the un-audited financial results for the quarter ending June 30, 2026. During this period, no transactions involving the company's securities will be permitted for insiders and their immediate relatives. The exact date of the board meeting to approve these results will be communicated later.

Indraprastha Medical Corporation Ltd approved audited financial results for the quarter/year ended March 31, 2026, and recommended a dividend of 40% (₹4 per equity share) for FY26, subject to shareholder approval at the AGM. The board meeting concluded at 4:35 p.m. on May 12, 2026. Auditors have issued an unmodified opinion on the financial results.

Indraprastha Medical Corporation Ltd. has scheduled a Board of Directors meeting for Tuesday, May 12, 2026. The agenda includes considering and approving the audited financial results for the quarter and year ended March 31, 2026. Furthermore, the Board will also discuss and potentially recommend a dividend on the company's equity shares for the financial year 2025-26. This announcement is made in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.